Neurocrine Biosciences Inc (NBIX)
125.00
+1.71
(+1.39%)
USD |
NASDAQ |
Nov 21, 16:00
126.09
+1.09
(+0.87%)
Pre-Market: 09:11
Neurocrine Biosciences Shareholders Equity (Quarterly): 2.719B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.719B |
| June 30, 2024 | 2.509B |
| March 31, 2024 | 2.386B |
| December 31, 2023 | 2.232B |
| September 30, 2023 | 2.002B |
| June 30, 2023 | 1.853B |
| March 31, 2023 | 1.684B |
| December 31, 2022 | 1.708B |
| September 30, 2022 | 1.545B |
| June 30, 2022 | 1.423B |
| March 31, 2022 | 1.391B |
| December 31, 2021 | 1.374B |
| September 30, 2021 | 1.346B |
| June 30, 2021 | 1.279B |
| March 31, 2021 | 1.206B |
| December 31, 2020 | 1.126B |
| September 30, 2020 | 804.30M |
| June 30, 2020 | 831.20M |
| March 31, 2020 | 700.30M |
| December 31, 2019 | 636.90M |
| September 30, 2019 | 574.52M |
| June 30, 2019 | 483.71M |
| March 31, 2019 | 409.28M |
| December 31, 2018 | 480.76M |
| September 30, 2018 | 447.51M |
| Date | Value |
|---|---|
| June 30, 2018 | 377.44M |
| March 31, 2018 | 364.49M |
| December 31, 2017 | 372.14M |
| September 30, 2017 | 347.51M |
| June 30, 2017 | 345.24M |
| March 31, 2017 | 247.14M |
| December 31, 2016 | 314.88M |
| September 30, 2016 | 351.65M |
| June 30, 2016 | 381.04M |
| March 31, 2016 | 412.96M |
| December 31, 2015 | 424.45M |
| September 30, 2015 | 446.94M |
| June 30, 2015 | 466.94M |
| March 31, 2015 | 484.73M |
| December 31, 2014 | 208.70M |
| September 30, 2014 | 224.04M |
| June 30, 2014 | 236.84M |
| March 31, 2014 | 247.06M |
| December 31, 2013 | 120.41M |
| September 30, 2013 | 129.29M |
| June 30, 2013 | 136.02M |
| March 31, 2013 | 144.95M |
| December 31, 2012 | 154.37M |
| September 30, 2012 | 143.30M |
| June 30, 2012 | 144.73M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
636.90M
Minimum
Dec 2019
2.719B
Maximum
Sep 2024
1.538B
Average
1.407B
Median
Shareholders Equity (Quarterly) Benchmarks
| Repligen Corp | 2.017B |
| West Pharmaceutical Services Inc | 2.752B |
| Bruker Corp | 1.807B |
| The Cooper Companies Inc | 7.925B |
| Integra Lifesciences Holdings Corp | 1.522B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.535B |
| Total Liabilities (Quarterly) | 816.10M |
| Current Ratio | 4.367 |
| Net Debt Paydown Yield | 0.29% |